COVID And Beyond: China Urged To Address Chronic Disease, Improve Access
Issues Laid Bare By Coronavirus
Executive Summary
Facing the aftermath of coronavirus disruption and supply chain reorganization, executives of multinational drug firms in China say the government needs to do more to help address a flurry of issues laid bare by the public health crisis.